InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

Current share price for HMD : $0.034 0.001 (2.86%)+

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 HeraBEAT receives upgraded TGA regulatory classification 20 Nov 2025 9:39AM $0.037 $0.034 fallen by 8.11%
$39 Change of address 14 Nov 2025 8:21AM $0.036 $0.034 fallen by 5.56%
$39 Quarterly Activities & Cashflow Report 31 Oct 2025 2:20PM $0.036 $0.034 fallen by 5.56%
$39 Application for quotation of securities - HMD 21 Oct 2025 8:27AM $0.036 $0.034 fallen by 5.56%
$39 Initial Director's Interest Notice 17 Oct 2025 11:04AM $0.039 $0.034 fallen by 12.82%
$39 Appointment of Non-Executive Director - Dr Sharon R. Howell 17 Oct 2025 8:24AM $0.035 $0.034 fallen by 2.86%
$39 HeraMED accelerates its next generation AI roadmap 22 Sep 2025 9:09AM $0.039 $0.034 fallen by 12.82%
$39 Appendix 4D and Half Year Report 28 Aug 2025 6:25PM $0.033 $0.034 risen by 3.03%
$39 Ceasing to be a substantial holder 21 Aug 2025 9:44AM $0.025 $0.034 risen by 36%
$39 Application for quotation of securities - HMD 15 Aug 2025 8:22AM $0.024 $0.034 risen by 41.67%
$39 Cleansing Notice 13 Aug 2025 10:00AM $0.021 $0.034 risen by 61.90%
$39 Notification regarding unquoted securities - HMD 13 Aug 2025 9:16AM $0.020 $0.034 risen by 70%
$39 Application for quotation of securities - HMD 13 Aug 2025 9:11AM $0.020 $0.034 risen by 70%
$39 Reinstatement to Quotation 5 Aug 2025 9:05AM $0.012 $0.034 risen by 183.33%
$39 Proposed issue of securities - HMD 4 Aug 2025 10:30AM $0.012 $0.034 risen by 183.33%
$39 Proposed issue of securities - HMD 4 Aug 2025 10:24AM $0.012 $0.034 risen by 183.33%
$39 Quarterly Activities & Cashflow Report 4 Aug 2025 10:24AM $0.012 $0.034 risen by 183.33%
$39 HeraMED completes $1.98 million placement 4 Aug 2025 10:23AM $0.012 $0.034 risen by 183.33%
$39 Suspension from Quotation 1 Aug 2025 9:30AM $0.012 $0.034 risen by 183.33%
$39 Trading Halt 31 Jul 2025 9:58AM $0.012 $0.034 risen by 183.33%
$39 Pause in Trading 31 Jul 2025 9:51AM $0.012 $0.034 risen by 183.33%
$39 Notification regarding unquoted securities - HMD 14 Jul 2025 11:14AM $0.012 $0.034 risen by 183.33%
$39 Notification of cessation of securities - HMD 14 Jul 2025 11:03AM $0.012 $0.034 risen by 183.33%
$39 Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC 16 Jun 2025 9:33AM $0.009 $0.034 risen by 277.78%
$39 Replacement Constitution 2 Jun 2025 8:54AM $0.013 $0.034 risen by 161.54%

51 - 75 of 537 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.